Literature DB >> 20146708

Innate pathways to B-cell activation and tolerance.

Steve P Crampton1, Elisaveta Voynova, Silvia Bolland.   

Abstract

B cells represent an important link between the adaptive and innate immune systems as they express both antigen-specific B-cell receptors (BCRs) as well as various Toll-like receptors (TLRs). Several checkpoints in B-cell development ensure that self-specific cells are eliminated from the mature B-cell repertoire to avoid harmful autoreactive responses. These checkpoints are controlled by BCR-mediated events but are also influenced by TLR-dependent signals from the innate immune system. Additionally, B-cell-intrinsic and extrinsic TLR signaling are critical for inflammatory events required for the clearance of microbial infections. Factors secreted by TLR-activated macrophages or dendritic cells directly influence the fate of protective and autoreactive B cells. Additionally, naive and memory B cells respond differentially to TLR ligands, as do different B-cell subsets. We review here recent literature describing intrinsic and extrinsic effects of TLR stimulation on the fate of B cells, with particular attention to autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146708      PMCID: PMC3422021          DOI: 10.1111/j.1749-6632.2009.05123.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  105 in total

Review 1.  Toll-like receptors: key activators of leucocytes and regulator of haematopoiesis.

Authors:  Anne F McGettrick; Luke A J O'Neill
Journal:  Br J Haematol       Date:  2007-10       Impact factor: 6.998

Review 2.  Regulation of autoreactive B cells: checkpoints and activation.

Authors:  Chuanlin Ding; Jun Yan
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007-03-09       Impact factor: 4.291

3.  Autoreactivity in human IgG+ memory B cells.

Authors:  Thomas Tiller; Makoto Tsuiji; Sergey Yurasov; Klara Velinzon; Michel C Nussenzweig; Hedda Wardemann
Journal:  Immunity       Date:  2007-02       Impact factor: 31.745

4.  Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6.

Authors:  Michelle A Kilmon; Nikki J Wagner; Alaina L Garland; Li Lin; Katja Aviszus; Lawrence J Wysocki; Barbara J Vilen
Journal:  Blood       Date:  2007-09-01       Impact factor: 22.113

5.  Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation.

Authors:  Jonathan A Deane; Prapaporn Pisitkun; Rebecca S Barrett; Lionel Feigenbaum; Terrence Town; Jerrold M Ward; Richard A Flavell; Silvia Bolland
Journal:  Immunity       Date:  2007-11-08       Impact factor: 31.745

6.  Anti-chromatin antibodies drive in vivo antigen-specific activation and somatic hypermutation of rheumatoid factor B cells at extrafollicular sites.

Authors:  Robin A Herlands; Jacqueline William; Uri Hershberg; Mark J Shlomchik
Journal:  Eur J Immunol       Date:  2007-12       Impact factor: 5.532

7.  Deficiency of the type I interferon receptor protects mice from experimental lupus.

Authors:  Dina C Nacionales; Kindra M Kelly-Scumpia; Pui Y Lee; Jason S Weinstein; Robert Lyons; Eric Sobel; Minoru Satoh; Westley H Reeves
Journal:  Arthritis Rheum       Date:  2007-11

8.  Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses.

Authors:  Stacey Walters; Kylie E Webster; Andrew Sutherland; Sandra Gardam; Joanna Groom; David Liuwantara; Eliana Mariño; Jessica Thaxton; Anita Weinberg; Fabienne Mackay; Robert Brink; Jonathon Sprent; Shane T Grey
Journal:  J Immunol       Date:  2009-01-15       Impact factor: 5.422

9.  Anti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockade.

Authors:  Wei Yu Lin; Qian Gong; Dhaya Seshasayee; Zhonghua Lin; Qinglin Ou; Shiming Ye; Eric Suto; Jean Shu; Wyne Pun Lee; Ching-Wei V Lee; Germaine Fuh; Maya Leabman; Suhasini Iyer; Kathy Howell; Thomas Gelzleichter; Joseph Beyer; Dimitry Danilenko; Sherry Yeh; Laura E DeForge; Allen Ebens; Jeffrey S Thompson; Christine Ambrose; Mercedesz Balazs; Melissa A Starovasnik; Flavius Martin
Journal:  Blood       Date:  2007-08-08       Impact factor: 22.113

Review 10.  Dendritic cells and the immunopathogenesis of systemic lupus erythematosus.

Authors:  Seetha Monrad; Mariana J Kaplan
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more
  26 in total

1.  Toll-like receptor 4-activated B cells out-compete Toll-like receptor 9-activated B cells to establish peripheral immunological tolerance.

Authors:  Melanie P Matheu; Yan Su; Milton L Greenberg; Caroline A Blanc; Ian Parker; David W Scott; Michael D Cahalan
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-17       Impact factor: 11.205

2.  Defective B-cell response to Toll-like receptor-9 ligands in common variable immunodeficiency.

Authors:  Julie Y Patel; Sapandeep K Singh; David P Huston
Journal:  Curr Allergy Asthma Rep       Date:  2010-09       Impact factor: 4.806

Review 3.  The double life of a B-1 cell: self-reactivity selects for protective effector functions.

Authors:  Nicole Baumgarth
Journal:  Nat Rev Immunol       Date:  2010-12-10       Impact factor: 53.106

Review 4.  The Gut Microbiome and Multiple Sclerosis.

Authors:  Javier Ochoa-Repáraz; Trevor O Kirby; Lloyd H Kasper
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

5.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Authors:  Eleni Arvaniti; Stavroula Ntoufa; Nikos Papakonstantinou; Tasoula Touloumenidou; Nikolaos Laoutaris; Achilles Anagnostopoulos; Klea Lamnissou; Federico Caligaris-Cappio; Kostas Stamatopoulos; Paolo Ghia; Marta Muzio; Chrysoula Belessi
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

6.  Immune tolerance induction to factor IX through B cell gene transfer: TLR9 signaling delineates between tolerogenic and immunogenic B cells.

Authors:  Xiaomei Wang; Babak Moghimi; Irene Zolotukhin; Laurence M Morel; Ou Cao; Roland W Herzog
Journal:  Mol Ther       Date:  2014-03-10       Impact factor: 11.454

Review 7.  Crosstalk between innate and adaptive immunity in hepatitis B virus infection.

Authors:  Li Wang; Kai Wang; Zhi-Qiang Zou
Journal:  World J Hepatol       Date:  2015-12-28

Review 8.  Review on Toll-Like Receptor Activation in Myasthenia Gravis: Application to the Development of New Experimental Models.

Authors:  Marieke Robinet; Solène Maillard; Mélanie A Cron; Sonia Berrih-Aknin; Rozen Le Panse
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 9.  The role of B-cells in heart failure.

Authors:  Andrea M Cordero-Reyes; Keith A Youker; Guillermo Torre-Amione
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 10.  The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.